The Society for Benefit-Cost Analysis March 2019 meeting in Washington, D.C. will highlight the results of the benefit-cost analysis reference case guidance project. This guidance is applicable to immunization and other policies in low- and middle-income countries. Dean Jamison, a member of the project Leadership team, will give a plenary address, which will be followed by a reception sponsored by the Bill & Melinda Gates Foundation and the Center for Health Decision Science, Harvard T.H. Chan School of Public Health. The conference will also feature a two part session in which key project contributors will illustrate the application of the guidance to a series of case studies and discuss future research needs.
More information on the project is available here: https://sites.sph.harvard.edu/bcaguidelines/. To learn more about the conference and to register, please visit the Society for Benefit-Cost Analysis website: https://benefitcostanalysis.org/2019-annual-conference.
Learn more about the theory and practice of benefit-cost analysis by reading the new Reference Case Guidelines for Benefit-Cost Analysis in Global Health and Development.
Join us for our iHEA pre-Congress workshop: The Benefit-Cost Analysis Reference Case: What It Is and How to Use It. This workshop provides an opportunity to learn more about new methodological guidance, including examples.
The Society for Benefit-Cost Analysis will be holding its first European conference at the Toulouse School of Economics on November 26-27, 2019. The organizers welcome submissions on immunization economics and other work.
Read the Journal for Benefit-Cost Analysis open-access special issue “Benefit Cost Analysis in Low- and Middle-Income Countries: Methods and Case Studies” and draft BCA reference case guidance. Draft comments are due by March 29, 2019
Draft guidelines for conducting benefit-cost analysis in low- and middle-income countries are now available for review. Comments are due March 29, 2019.
Join us on March 15th to hear Dean Jamison speak on “Valuing Investments in Health for Development: Reflections on Three Dynamic Decades” at the Society for the Benefit Cost-Analysis annual meeting in Washington, D.C.
Upcoming March meeting in Washington D.C. will highlight the results of the benefit-cost analysis reference case guidance project, applicable to immunization and other policies in low- and middle-income countries. Dean Jamison plenary speaker.
Following a call for concept notes last year, the VoVRN Secretariat, members of the Steering Committee, and external expert reviewers identified promising studies to recommend for funding. Learn more about these projects here